| scholarly article | Q13442814 |
| P50 | author | Jacques J. G. H. M. Bergman | Q90765858 |
| David Hopkins | Q91314546 | ||
| P2093 | author name string | Guido Costamagna | |
| Jan Tijssen | |||
| Frits Holleman | |||
| Ann Mertens | |||
| Rehan Haidry | |||
| Max Nieuwdorp | |||
| Raf Bisschops | |||
| Manoel Galvao Neto | |||
| Jacques Devière | |||
| Bu'Hussain Hayee | |||
| Caterina Guidone | |||
| Cormac Magee | |||
| Laurent Crenier | |||
| Annieke C G van Baar | |||
| Leonardo Rodriguez Grunert | |||
| Paulina Vignolo | |||
| P2860 | cites work | Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus | Q22241140 |
| Intestinal permeability--a new target for disease prevention and therapy | Q27015884 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 | Q29620059 | ||
| Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes | Q33746480 | ||
| Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery. | Q53784109 | ||
| Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur | Q74655569 | ||
| Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes | Q86169332 | ||
| Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q34457919 | ||
| Microbial modulation of insulin sensitivity | Q35235971 | ||
| Long-term follow-up after bariatric surgery: a systematic review. | Q35237039 | ||
| A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass | Q36942098 | ||
| Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia | Q38686646 | ||
| Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. | Q38729150 | ||
| Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry | Q42638070 | ||
| Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases | Q46593451 | ||
| Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey | Q46966712 | ||
| Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial | Q47965626 | ||
| Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. | Q48114175 | ||
| The Duodenum harbors a Broad Untapped Therapeutic Potential | Q50083641 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 295-303 | |
| P577 | publication date | 2019-07-22 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study | |
| P478 | volume | 69 |
| Q89624077 | Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results |
| Q99610102 | Overview of bariatric and metabolic endoscopy interventions |
| Q89624069 | The changing face of hepatology |
| Q96766399 | Training in bariatric and metabolic endoscopy |
Search more.